Back
GT Biopharma, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
GTBP
GT Biopharma, Inc.
Last Price:
$0.83
Seasonality Move:
-4.49%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GTBP is experiencing slight buying pressure.
GT Biopharma, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.75 | Buy |
| 20-day SMA: | 0.71 | Buy |
| 50-day SMA: | 0.7 | Buy |
| 200-day SMA: | 1.66 | Sell |
| 8-day EMA: | 0.77 | Buy |
| 20-day EMA: | 0.73 | Buy |
| 50-day EMA: | 0.76 | Buy |
| 200-day EMA: | 1.52 | Sell |
GT Biopharma, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 61.35 | Buy |
| Chaikin Money Flow: | 282414 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.64 - 0.78) | Buy |
| Bollinger Bands (100): | (0.54 - 1.16) | Sell |
GT Biopharma, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for GT Biopharma, Inc. Stock
Is GT Biopharma, Inc. Stock a Buy?
-
GT Biopharma, Inc. share price is 0.83 while GTBP 8-day simple moving average is 0.75, which is a Buy signal.
-
The stock price of GTBP is 0.83 while GT Biopharma, Inc. 20-day SMA is 0.71, which makes it a Buy.
-
GT Biopharma, Inc. 50-day simple moving average is 0.70 while GTBP share price is 0.83, making it a Buy technically.
-
GTBP stock price is 0.83 and GT Biopharma, Inc. 200-day simple moving average is 1.66, creating a Sell signal.
GTBP Technical Analysis vs Fundamental Analysis
Sell
28
GT Biopharma, Inc. (GTBP)
is a Sell
Is GT Biopharma, Inc. a Buy or a Sell?
-
GT Biopharma, Inc. stock is rated a SellThe current GT Biopharma, Inc. [GTBP] share price is $0.83. The Score for GTBP is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
GT Biopharma, Inc. Stock Info
Market Cap:
8.9M
Price in USD:
0.83
Share Volume:
2M
GT Biopharma, Inc. 52-Week Range
52-Week High:
3.85
52-Week Low:
0.54
Sell
28
GT Biopharma, Inc. (GTBP)
is a Sell
GT Biopharma, Inc. Share Price Forecast
-
What is the GT Biopharma, Inc. stock price today?The GT Biopharma, Inc. stock price is 0.83 USD today.
-
Will GTBP stock go up or go down?GT Biopharma, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is GT Biopharma, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, GT Biopharma, Inc. is overvalued.
Is GT Biopharma, Inc. Stock a Buy?
-
GT Biopharma, Inc. share price is 0.83 while GTBP 8-day exponential moving average is 0.77, which is a Buy signal.
-
The stock price of GTBP is 0.83 while GT Biopharma, Inc. 20-day EMA is 0.73, which makes it a Buy.
-
GT Biopharma, Inc. 50-day exponential moving average is 0.76 while GTBP share price is 0.83, making it a Buy technically.
-
GTBP stock price is 0.83 and GT Biopharma, Inc. 200-day simple moving average is 1.52, creating a Sell signal.
Fundamental Analysis of GT Biopharma, Inc.
Is GT Biopharma, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.32 per share, and an increase next year of $0.93 per share.
Technical Analysis of GT Biopharma, Inc.
Should I short GT Biopharma, Inc. stock?
-
GTBP Moving Average Covergence Divergence (MACD) indicator is 0.02, suggesting GT Biopharma, Inc. is a Buy
-
GT Biopharma, Inc. Relative Strength Index (RSI) is 61.35, which suggest GT Biopharma, Inc. is overbought
-
The Bollinger Bands (25) for GT Biopharma, Inc. is (0.64 - 0.78), which suggest GT Biopharma, Inc. is a Sell
-
The Bollinger Bands (100) for GT Biopharma, Inc. is (0.54 - 1.16), which suggest GT Biopharma, Inc. is a Sell
* GT Biopharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.